(Q69468134)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3691597%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

title

The pharmacokinetics of indoramin and 6-hydroxyindoramin in poor and extensive hydroxylators of debrisoquine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3691597%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

1 reference

1 reference

D M Pierce

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3691597%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

S E Smith

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3691597%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

R A Franklin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3691597%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3691597%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

2 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3691597%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3691597%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3691597%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

page(s)

59-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3691597%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00610381

2 October 2019

exact match

0 references

cites work

Determination of therapeutic concentrations of indoramin by liquid chromatography with fluorimetric detection

1 reference

12 December 2020

Studies on the biotransformation of indoramin in the patas monkey

1 reference

12 December 2020

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

12 December 2020

Pharmacokinetics and systemic availability of the antihypertensive agent indoramin and its metabolite 6-hydroxyindoramin in healthy subjects

1 reference

12 December 2020

Influence of oxidation polymorphism on phenformin kinetics and dynamics

1 reference

12 December 2020

Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice

1 reference

12 December 2020

Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings]

1 reference

12 December 2020

Studies on the metabolism of the new anti-hypertensive agent, indoramin, in man

1 reference

12 December 2020

Pharmacokinetics of intravenous indoramin in middle-aged male and female volunteers

1 reference

12 December 2020

Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical Significance

1 reference

12 December 2020

Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine

1 reference

12 December 2020

Pharmacokinetics of oral indoramin in elderly and middle-aged female volunteers

1 reference

12 December 2020

Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers

1 reference

12 December 2020

Pharmacokinetics of oral indoramin

1 reference

12 December 2020